Ono Pharmaceutical and Vertex Pharmaceuticals signed an exclusive collaboration for Povetacicept in Japan and South Korea.
3 reports, 1 independent
Updated Aug 4
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ono Pharmaceutical and Vertex Pharmaceuticals signed an exclusive collaboration for Povetacicept in Japan and South Korea.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA accepted Povetacicept BLA; ALYFTREK adoption strong in Europe; Crinetics acquisition proposed.1 source
- Ono and Vertex signed a license deal for Povetacicept in Japan and South Korea.
Keep exploring
The entities involved
-
Ono Pharmaceutical
Japanese pharmaceutical company
Nothing else this week.
-
Vertex Pharmaceuticals
American pharmaceutical company
Coverage
Newest first; wire copies grouped- yahoo.com
- Unknown outlet
- Unknown outlet